Entrepreneurs: Don't Be Evil

It's difficult to read about the ongoing saga of Martin Shkreli, hedge fund founder and pharmaceutical CEO, without feeling the overwhelming need to take a shower. Shkreli first burst onto the scene earlier this year when his company Turing Pharmaceutical acquired the rights to the AIDS drug Daraprim and hiked the price of the medication by 5,000%, from $13.53 per dose to $750.